238 related articles for article (PubMed ID: 34640387)
41. The neuroprotective effects of oxygen therapy in Alzheimer's disease: a narrative review.
Yang C; Yang Q; Xiang Y; Zeng XR; Xiao J; Le WD
Neural Regen Res; 2023 Jan; 18(1):57-63. PubMed ID: 35799509
[TBL] [Abstract][Full Text] [Related]
42. Inflammation/bioenergetics-associated neurodegenerative pathologies and concomitant diseases: a role of mitochondria targeted catalase and xanthophylls.
Filippov MA; Tatarnikova OG; Pozdnyakova NV; Vorobyov VV
Neural Regen Res; 2021 Feb; 16(2):223-233. PubMed ID: 32859768
[TBL] [Abstract][Full Text] [Related]
43. Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers.
Gubandru M; Margina D; Tsitsimpikou C; Goutzourelas N; Tsarouhas K; Ilie M; Tsatsakis AM; Kouretas D
Food Chem Toxicol; 2013 Nov; 61():209-14. PubMed ID: 23871825
[TBL] [Abstract][Full Text] [Related]
44. Alpha-1-Antichymotrypsin: A Common Player for Type 2 Diabetes and Alzheimer's Disease.
Guzmán-Herrera N; Pérez-Nájera VC; Salazar-Olivo LA
Curr Diabetes Rev; 2021; 17(5):e121020186817. PubMed ID: 33045976
[TBL] [Abstract][Full Text] [Related]
45. Dietary Modulation of Oxidative Stress in Alzheimer's Disease.
Thapa A; Carroll NJ
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28753984
[TBL] [Abstract][Full Text] [Related]
46. Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.
Daulatzai MA
Neurotox Res; 2016 Oct; 30(3):295-337. PubMed ID: 27339162
[TBL] [Abstract][Full Text] [Related]
47. Medical Comorbidity in Alzheimer's Disease: A Nested Case-Control Study.
Wang JH; Wu YJ; Tee BL; Lo RY
J Alzheimers Dis; 2018; 63(2):773-781. PubMed ID: 29660933
[TBL] [Abstract][Full Text] [Related]
48. Pimavanserin for the treatment of psychosis in Alzheimer's disease: A literature review.
Srinivasan S; Tampi RR; Balaram K; Kapoor A
World J Psychiatry; 2020 Jul; 10(7):162-174. PubMed ID: 32844093
[TBL] [Abstract][Full Text] [Related]
49. Asthma and Chronic Obstructive Pulmonary Disease as a Comorbidity and Association with the Choice of Antidementia Medication Among Persons with Alzheimer's Disease.
Lampela P; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
J Alzheimers Dis; 2020; 73(3):1243-1251. PubMed ID: 31929157
[TBL] [Abstract][Full Text] [Related]
50. Coexistence of Multiple Sclerosis and Alzheimer's disease: A review.
Luczynski P; Laule C; Hsiung GR; Moore GRW; Tremlett H
Mult Scler Relat Disord; 2019 Jan; 27():232-238. PubMed ID: 30415025
[TBL] [Abstract][Full Text] [Related]
51. Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer's Disease?
Codocedo JF; Ríos JA; Godoy JA; Inestrosa NC
Mol Neurobiol; 2016 May; 53(4):2320-38. PubMed ID: 25976367
[TBL] [Abstract][Full Text] [Related]
52. Oxidative stress hypothesis in Alzheimer's disease: a reappraisal.
Praticò D
Trends Pharmacol Sci; 2008 Dec; 29(12):609-15. PubMed ID: 18838179
[TBL] [Abstract][Full Text] [Related]
53. The Action of Polyphenols in Diabetes Mellitus and Alzheimer's Disease: A Common Agent for Overlapping Pathologies.
Silveira AC; Dias JP; Santos VM; Oliveira PF; Alves MG; Rato L; Silva BM
Curr Neuropharmacol; 2019; 17(7):590-613. PubMed ID: 30081787
[TBL] [Abstract][Full Text] [Related]
54. Atrial fibrillation and Alzheimer's disease: A conundrum.
Benenati S; Canale C; De Marzo V; Della Bona R; Rosa GM; Porto I
Eur J Clin Invest; 2021 Jul; 51(7):e13451. PubMed ID: 33219514
[TBL] [Abstract][Full Text] [Related]
55. The Role of Vascular Risk Factors in Biomarker-Based AT(N) Groups: A German-Dutch Memory Clinic Study.
Kučikienė D; Costa AS; Banning LCP; van Gils V; Schulz JB; Ramakers IHGB; Verhey FRJ; Vos SJB; Reetz K
J Alzheimers Dis; 2022; 87(1):185-195. PubMed ID: 35275532
[TBL] [Abstract][Full Text] [Related]
56. The long-lived Octodon degus as a rodent drug discovery model for Alzheimer's and other age-related diseases.
Hurley MJ; Deacon RMJ; Beyer K; Ioannou E; Ibáñez A; Teeling JL; Cogram P
Pharmacol Ther; 2018 Aug; 188():36-44. PubMed ID: 29514054
[TBL] [Abstract][Full Text] [Related]
57. A how-to guide for a precision medicine approach to the diagnosis and treatment of Alzheimer's disease.
Devi G
Front Aging Neurosci; 2023; 15():1213968. PubMed ID: 37662550
[TBL] [Abstract][Full Text] [Related]
58. Non-Enzymatic Antioxidants against Alzheimer's Disease: Prevention, Diagnosis and Therapy.
Varesi A; Campagnoli LIM; Carrara A; Pola I; Floris E; Ricevuti G; Chirumbolo S; Pascale A
Antioxidants (Basel); 2023 Jan; 12(1):. PubMed ID: 36671042
[TBL] [Abstract][Full Text] [Related]
59. Natural antioxidants that act against Alzheimer's disease through modulation of the NRF2 pathway: a focus on their molecular mechanisms of action.
Sidiropoulou GA; Metaxas A; Kourti M
Front Endocrinol (Lausanne); 2023; 14():1217730. PubMed ID: 37465125
[TBL] [Abstract][Full Text] [Related]
60. The effect of comorbidities on survival in persons with Alzheimer's disease: a matched cohort study.
Rajamaki B; Hartikainen S; Tolppanen AM
BMC Geriatr; 2021 Mar; 21(1):173. PubMed ID: 33750334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
